GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 299 filers reported holding GW PHARMACEUTICALS PLC in Q2 2020. The put-call ratio across all filers is 1.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $3,562,000 | +16.1% | 36,500 | +46.0% | 0.26% | +17.9% |
| Q2 2020 | $3,069,000 | -37.6% | 25,000 | -55.4% | 0.22% | -50.2% |
| Q1 2020 | $4,917,000 | +8.1% | 56,000 | +28.7% | 0.45% | +78.6% |
| Q4 2019 | $4,547,000 | -70.7% | 43,500 | -67.8% | 0.25% | -76.9% |
| Q3 2019 | $15,518,000 | +43.9% | 135,000 | +116.0% | 1.09% | +44.6% |
| Q2 2019 | $10,785,000 | +19.5% | 62,500 | +16.8% | 0.75% | +19.5% |
| Q1 2019 | $9,023,000 | +73.4% | 53,500 | 0.0% | 0.63% | +39.7% |
| Q4 2018 | $5,204,000 | – | 53,500 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 450,000 | $55,224,000 | 4.41% |
| Parkman Healthcare Partners LLC | 119,778 | $14,699,000 | 4.14% |
| Sio Capital Management, LLC | 94,984 | $11,656,000 | 3.40% |
| Tamarack Advisers, LP | 90,000 | $11,045,000 | 3.08% |
| Copernicus Capital Management, LLC | 22,000 | $2,700,000 | 2.96% |
| Integral Health Asset Management, LLC | 75,000 | $9,204,000 | 2.76% |
| ETF MANAGERS GROUP, LLC | 480,145 | $58,923,000 | 2.09% |
| AdvisorShares Investments LLC | 29,758 | $3,652,000 | 1.55% |
| Redwood Investments, LLC | 130,444 | $16,008,000 | 1.42% |
| CLOUGH CAPITAL PARTNERS L P | 100,746 | $12,364,000 | 1.21% |